Table 2. Summary of data.*.

Number of patients	11
DPP-IV inhibitor	64% Vildagliptin (7/11) 36% Sitagliptin (4/11)
Sex (M/F)	64% M (7/11) 36% F (4/11)
Average age (yrs)	72 (+/- 11)
Period before onset of Bullous pemphigoid (in months)	6 (+/- 8)
Treatment (topical vs oral steroid vs other)	Topical: 55% (6/11) Oral: 36% (4/11) Other: 9% (1/11)
Outcome (Sustained or not)	Sustained: 55% (6/11) Refractory: 45% (5/11) Refractory until gliptin stopped: 27% (3/11)
*The average is taken to be the median +/- the inter quartile range.